Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)

Blood

Volumn 117, Issue 5, 2011, Pages 1522-1529

  Schmid, Jana Pachlopnik ^a,b   Canioni, Danielle ^a   Moshous, Despina ^a,b   Touzot, Fabien ^a   Mahlaoui, Nizar ^a   Hauck, Fabian ^a,b   Kanegane, Hirokazu ^c   Lopez Granados, Eduardo ^d   Mejstrikova, Ester ^e   Pellier, Isabelle ^f,g   Galicier, Lionel ^h   Galambrun, Claire ⁱ   Barlogis, Vincent ⁱ   Bordigoni, Pierre ^j   Fourmaintraux, Alain ^k   Hamidou, Mohamed ^l   Dabadie, Alain ^m   Le Deist, Françoise ⁿ   Haerynck, Filomeen ^o   Ouachée Chardin, Marie ^p   Rohrlich, Pierre ^q,r,s   Stephan, Jean Louis ^t   Lenoir, Christelle ^a   Rigaud, Stéphanie ^a,b   Lambert, Nathalie ^a   Milili, Michèle ^u   Schiff, Claudin ^u   Chapel, Helen ^d   Picard, Capucine ^a,b   De Saint Basile, Geneviève ^a,b   Blanche, Stéphane ^a   Fischer, Alain ^a,b   Latour, Sylvain ^a,b   more..

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF TOYAMA   (Japan)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e CHARLES UNIVERSITY   (Czech Republic)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g Team 12   (France)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ TIMONE HOSPITAL   (France)

^j UNIVERSITY HOSPITAL OF NANCY   (France)

^k Groupe Hospitalier Sud Reunion   (France)

^l NANTES UNIVERSITY HOSPITAL   (France)

^m RENNES UNIVERSITY HOSPITAL   (France)

ⁿ UNIVERSITY OF MONTREAL   (Canada)

^o GHENT UNIVERSITY HOSPITAL   (Belgium)

^p HÔPITAL ROBERT DEBRÉ   (France)

^q INSERM   (France)

^r UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^s UNIVERSITY HOSPITAL OF BESANÇON   (France)

^t HÔPITAL NORD   (France)

^u CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN A; IMMUNOGLOBULIN; INFLIXIMAB; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; X LINKED INHIBITOR OF APOPTOSIS;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ASSESSMENT; COHORT ANALYSIS; CORTICOSTEROID THERAPY; CYTOPENIA; DISEASE ASSOCIATION; DYSGAMMAGLOBULINEMIA; EPSTEIN BARR VIRUS INFECTION; FEMALE; FEVER; GENE MUTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEMORRHAGIC COLITIS; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN DEFICIENCY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SPLENOMEGALY; SURVIVAL RATE; X LINKED LYMPHOPROLIFERATIVE SYNDROME TYPE 1; X LINKED LYMPHOPROLIFERATIVE SYNDROME TYPE 2;

EID: 79551644967     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-07-298372     Document Type: Article

References (36)

1. Purtilo DT, Cassel C, Yang JP. Letter: fatal infectious mononucleosis in familial lymphohistiocytosis. N Engl J Med. 1974;291(14):736.
2. Purtilo DT, Cassel CK, Yang JP, Harper R. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet. 1975;1(7913):935-940.
3. Seemayer TA, Gross TG, Egeler RM, et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res. 1995;38(4):471-478.
4. Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-131.
5. Sayos J, Wu C, Morra M, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 1998;395(6701):462-469.
6. Coffey AJ, Brooksbank RA, Brandau O, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet. 1998;20(2):129-135.
7. Rigaud S, Fondaneche MC, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006;444(7115):110-114.
8. Zhao M, Kanegane H, Ouchi K, Imamura T, Latour S, Miyawaki T.Anovel XIAP mutation in a Japanese boy with recurrent pancytopenia and splenomegaly. Haematologica. 2009;95(4):688-689.
9. Marsh RA, Madden L, Kitchen BJ, et al. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood. 2010;7(116):1079-1082.
10. Gaspar HB, Sharifi R, Gilmour KC, Thrasher AJ. X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective. Br J Haematol. 2002;119(3):585-595.
11. Nichols KE, Ma CS, Cannons JL, Schwartzberg PL, Tangye SG. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol Rev. 2005;203:180-199.
12. Grierson HL, Skare J, Hawk J, Pauza M, Purtilo DT. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. Am J Med Genet. 1991;40(3):294-297.
13. Dutz JP, Benoit L, Wang X, et al. Lymphocytic vasculitis in X-linked lymphoproliferative disease. Blood. 2001;97(1):95-100.
14. Ma CS, Nichols KE, Tangye SG. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu Rev Immunol. 2007;25:337-379.
15. Eckelman BP, Salvesen GS, Scott FL. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 2006;7(10):988-994.
16. Galban S, Duckett CS. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ. 2009;17(1):54-60.
17. Verhelst H, Van Coster R, Bockaert N, et al. Limbic encephalitis as presentation of a SAP deficiency. Neurology. 2007;69(2):218-219.
18. Knight C, Murray KF. Hepatobiliary associations with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2009;3(6):681-691.
19. Hervier B, Latour S, Loussouarn D, et al. An atypical case of X-linked lymphoproliferative disease revealed as a late cerebral lymphoma. J Neuroimmunol. 2010;218(1-2):125-128.
20. Rougemont AL, Fournet JC, Martin SR, et al. Chronic active gastritis in X-linked lymphoproliferative disease. Am J Surg Pathol. 2008;32(2):323-328.
21. Sumegi J, Huang D, Lanyi A, et al. Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood. 2000;96(9):3118-3125.
22. Dong Z, Cruz-Munoz ME, Zhong MC, Chen R, Latour S, Veillette A. Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nat Immunol. 2009;10(9):973-980.
23. Bloch-Queyrat C, Fondaneche MC, Chen R, et al. Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn. J Exp Med. 2005;202(1):181-192.
24. Parolini S, Bottino C, Falco M, et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med. 2000;192(3):337-346.
25. Dupre L, Andolfi G, Tangye SG, et al. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. Blood. 2005;105(11):4383-4389.
26. Sharifi R, Sinclair JC, Gilmour KC, et al. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. Blood. 2004;103(10):3821-3827.
27. Hislop AD, Palendira U, Leese AM, et al. Impaired Epstein-Barr virus-specific CD8+ T cell function in X-linked lymphoproliferative disease is restricted to SLAM family positive B cell targets. Blood. Blood. 2010;116(17):3249-3257.
28. Fischer A, Latour S, de Saint Basile G. Genetic defects affecting lymphocyte cytotoxicity. Curr Opin Immunol. 2007;19(3):348-353.
29. Veillette A, Dong Z, Perez-Quintero LA, Zhong MC, Cruz-Munoz ME. Importance and mechanism of 'switch' function of SAP family adapters. Immunol Rev. 2009;232(1):229-239.
30. Krieg A, Correa RG, Garrison JB, et al. XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci U S A. 2009;106(34):14524-14529.
31. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411(6837):599-603.
32. Snow AL, Marsh RA, Krummey SM, et al. Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. J Clin Invest. 2009;119(10):2976-2989.
33. Chen G, Tai AK, Lin M, Chang F, Terhorst C, Huber BT. Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice. J Immunol. 2005;175(4):2212-2218.
34. Crotty S, Kersh EN, Cannons J, Schwartzberg PL, Ahmed R. SAP is required for generating long-term humoral immunity. Nature. 2003;421(6920):282-287.
35. Qi H, Cannons JL, Klauschen F, Schwartzberg PL, Germain RN. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature. 2008;455(7214):764-769.
36. Ma CS, Hare NJ, Nichols KE, et al. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. J Clin Invest. 2005;115(4):1049-1059.